Sandu Pharmaceuticals standalone net profit rises 75.00% in the December 2025 quarter
Sales rise 2.12% to Rs 18.76 crore
Net profit of Sandu Pharmaceuticals rose 75.00% to Rs 0.98 crore in the quarter ended December 2025 as against Rs 0.56 crore during the previous quarter ended December 2024. Sales rose 2.12% to Rs 18.76 crore in the quarter ended December 2025 as against Rs 18.37 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales18.7618.37 2 OPM %5.605.44 -PBDT1.030.99 4 PBT0.860.80 8 NP0.980.56 75Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 07 2026 | 9:08 AM IST